Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension
- 22 June 2004
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 148 (1), 172
- https://doi.org/10.1016/j.ahj.2004.03.025
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Effects of the Early ACE Inhibition in Diabetic Nonthrombolyzed Patients With Anterior Acute Myocardial InfarctionDiabetes Care, 2003
- Nitric Oxide–Releasing DrugsAnnual Review of Pharmacology and Toxicology, 2003
- Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: Results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) studyAmerican Heart Journal, 2003
- Molecular Plasticity of Vascular Wall During N G -Nitro- l -Arginine Methyl Ester–Induced HypertensionHypertension, 2000
- 1,4-Dihydropyridine Calcium Channel Blockers Inhibit Plasma and LDL Oxidation and Formation of Oxidation-Specific Epitopes in the Arterial Wall and Prolong Survival in Stroke-Prone Spontaneously Hypertensive RatsStroke, 1999
- Asymmetrical Dimethylarginine, an Endogenous Nitric Oxide Synthase Inhibitor, in Experimental HypertensionHypertension, 1997
- Fosinopril Reduces ADP-Induced Platelet Aggregation in Hypertensive PatientsJournal of Cardiovascular Pharmacology, 1996
- Low-density lipoprotein oxidation in essential hypertensionJournal Of Hypertension, 1993
- Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.Hypertension, 1990
- Effects of Captopril on Atherosclerosis in Cynomolgus MonkeysJournal of Cardiovascular Pharmacology, 1990